ClinVar Miner

Submissions for variant NM_015215.4(CAMTA1):c.4690-2A>G

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
New York Genome Center RCV004555212 SCV005044182 likely pathogenic Cerebellar dysfunction with variable cognitive and behavioral abnormalities 2023-01-07 criteria provided, single submitter clinical testing The de novo heterozygous c.4690-2A>G splice-site variant in CAMTA1 has not previously been reported in the literature or public variant repositories (ClinVar and LOVD) and is absent from population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.4690-2A>G variant in CAMTA1 affects the canonical splice acceptor site of intron 19 (of 22) and is predicted to cause abnormal mRNA splicing, either subjecting the transcript to nonsense-mediated mRNA decay or resulting in an abnormal protein product if the message is used for protein translation. Based on available evidence this de novo heterozygous c.4690-2A>G variant identified in CAMTA1 is classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.